Lanreotide

Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression

Items (National)

2,841

NHS Cost

£2.4M

Practices

308

Avg per Practice

Overview

Lanreotide is prescribed by 308 GP practices across England. In the last 12 months, 2,841 items were prescribed at a total cost of £2,353,538 to the NHS. It is classified under BNF Chapter Malignant Disease and Immunosuppression, Section Sex hormones and hormone antagonists in malignant disease.

Monthly Prescribing Trend

No monthly data available.

Prescribing by Area

Area	Items	Practices	Avg/Practice	vs National
PO	155	9	17	+87.0% ▲
DE	118	9	13	+42.4% ▲
LS	113	7	16	+75.0% ▲
GL	112	6	19	+103.3% ▲

Top Prescribing Practices

Practice	Items
JAMES STREET GROUP PRACT	41
SWAN MEDICAL GROUP	38
THE WILLOW GROUP	37

View all 308 practices →

BNF Classification

Chapter: Malignant Disease and Immunosuppression
Section: Sex hormones and hormone antagonists in malignant disease
Paragraph: Hormone antagonists

Related drugs in this section

Letrozole Tamoxifen citrate Anastrozole Leuprorelin acetate Goserelin acetate

Explore More

Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.